Stock Scorecard

Stock Summary for Harmony Biosciences Holdings Inc (HRMY) - $39.40 as of 1/12/2026 8:02:24 PM EST

Total Score

18 out of 30

Safety Score

52 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for HRMY

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for HRMY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for HRMY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for HRMY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for HRMY (52 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for HRMY

Company Overview
Ticker HRMY
Company Name Harmony Biosciences Holdings Inc
Country USA
Description Harmony Biosciences Holdings, Inc. is a pioneering pharmaceutical company located in Plymouth Meeting, Pennsylvania, dedicated to developing innovative therapies for rare neurological disorders, particularly narcolepsy. The company is well-positioned in the specialty pharmaceuticals market, leveraging a strong product pipeline and advanced R&D capabilities to tackle significant unmet medical needs in the neurology sector. By focusing on rare diseases, Harmony aims to deliver substantial growth while significantly improving patient quality of life, thereby reinforcing its role as a critical player in the advancement of healthcare solutions.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 39.40
Price 4 Years Ago 55.10
Last Day Price Updated 1/12/2026 8:02:24 PM EST
Last Day Volume 440,359
Average Daily Volume 651,503
52-Week High 40.93
52-Week Low 25.52
Last Price to 52 Week Low 54.39%

Valuation Measures
Trailing PE 11.95
Industry PE 59.48
Sector PE 123.98
5-Year Average PE 20.96
Free Cash Flow Ratio 3.51
Industry Free Cash Flow Ratio 12.53
Sector Free Cash Flow Ratio 29.04
Current Ratio Most Recent Quarter 3.75
Total Cash Per Share 11.23
Book Value Per Share Most Recent Quarter 14.50
Price to Book Ratio 2.61
Industry Price to Book Ratio 66.60
Sector Price to Book Ratio 24.69
Price to Sales Ratio Twelve Trailing Months 2.64
Industry Price to Sales Ratio Twelve Trailing Months 31.26
Sector Price to Sales Ratio Twelve Trailing Months 19.33
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 2

Share Statistics
Total Shares Outstanding 57,596,000
Market Capitalization 2,269,282,400
Institutional Ownership 88.59%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 10.10%
Annual Earnings Growth 12.91%
Reported EPS 12 Trailing Months 3.17
Reported EPS Past Year 2.78
Reported EPS Prior Year 2.74
Net Income Twelve Trailing Months 185,676,000
Net Income Past Year 145,493,000
Net Income Prior Year 128,853,000
Quarterly Revenue Growth YOY 28.70%
5-Year Revenue Growth 160.18%
Operating Margin Twelve Trailing Months 27.40%

Balance Sheet
Total Cash Most Recent Quarter 646,999,000
Total Cash Past Year 453,001,000
Total Cash Prior Year 311,660,000
Net Cash Position Most Recent Quarter 498,493,000
Net Cash Position Past Year 289,985,000
Long Term Debt Past Year 163,016,000
Long Term Debt Prior Year 178,566,000
Total Debt Most Recent Quarter 148,506,000
Equity to Debt Ratio Past Year 0.80
Equity to Debt Ratio Most Recent Quarter 0.85
Total Stockholder Equity Past Year 659,155,000
Total Stockholder Equity Prior Year 466,992,000
Total Stockholder Equity Most Recent Quarter 835,123,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 296,894,000
Free Cash Flow Per Share Twelve Trailing Months 5.15
Free Cash Flow Past Year 218,668,000
Free Cash Flow Prior Year 219,075,000

Options
Put/Call Ratio 0.01
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.49
MACD Signal 0.64
20-Day Bollinger Lower Band 24.41
20-Day Bollinger Middle Band 33.63
20-Day Bollinger Upper Band 42.84
Beta 0.84
RSI 63.58
50-Day SMA 33.85
150-Day SMA 33.38
200-Day SMA 37.44

System
Modified 1/10/2026 12:40:03 AM EST